These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6231845)
1. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen. Martel RR; Klicius J; Metcalf G Agents Actions; 1984 Feb; 14(2):257-64. PubMed ID: 6231845 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats. Martel RR; Klicius J; Metcalf G; Rona GA Agents Actions; 1984 Oct; 15(3-4):403-12. PubMed ID: 6240930 [TBL] [Abstract][Full Text] [Related]
3. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage. Weichman BM; Chau TT; Rona G Arthritis Rheum; 1987 Apr; 30(4):466-70. PubMed ID: 2953342 [TBL] [Abstract][Full Text] [Related]
4. Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat. Lee DK; Chau TT; Weichman BM; Wooley PH Proc Soc Exp Biol Med; 1988 Mar; 187(3):273-7. PubMed ID: 2964641 [TBL] [Abstract][Full Text] [Related]
5. Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions. Yoshida-Suzuka H; Nakamura Y; Shibata Y; Kimura K Agents Actions; 1991 Jul; 33(3-4):310-3. PubMed ID: 1835269 [TBL] [Abstract][Full Text] [Related]
6. Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat. Calhoun W; Gilman SC; Datko LJ; Copenhaver TW; Carlson RP Agents Actions; 1992 May; 36(1-2):99-106. PubMed ID: 1414694 [TBL] [Abstract][Full Text] [Related]
7. Application of computer-based histomorphometry to the quantitative analysis of methylprednisolone-treated adjuvant arthritis in rats. Jee WS; Li XJ; Ke HZ; Li M; Smith RJ; Dunn CJ Bone Miner; 1993 Sep; 22(3):221-47. PubMed ID: 8268755 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac. Hayward MA; Howard GA; Neuman RG; Wood DD; Weichman BM; Van Sickle DC Agents Actions; 1989 Mar; 26(3-4):310-8. PubMed ID: 2525314 [TBL] [Abstract][Full Text] [Related]
9. Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin A. del Pozo E; Graeber M; Elford P; Payne T Arthritis Rheum; 1990 Feb; 33(2):247-52. PubMed ID: 2306292 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837 [TBL] [Abstract][Full Text] [Related]
11. Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat. Engelhardt G; Homma D; Schnitzler C Inflamm Res; 1995 Dec; 44(12):548-55. PubMed ID: 8788236 [TBL] [Abstract][Full Text] [Related]
12. Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study. Waltham-Weeks CD Curr Med Res Opin; 1987; 10(8):540-7. PubMed ID: 2960494 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs. Inoue K; Fujisawa H; Motonaga A; Inoue Y; Kyoi T; Ueda F; Kimura K Biol Pharm Bull; 1994 Dec; 17(12):1577-83. PubMed ID: 7735198 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. Campagnuolo G; Bolon B; Feige U Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878 [TBL] [Abstract][Full Text] [Related]
15. Effects of antiinflammatory drugs on arthritic cartilage: a high-frequency quantitative ultrasound study in rats. Jaffré B; Watrin A; Loeuille D; Gillet P; Netter P; Laugier P; Saïed A Arthritis Rheum; 2003 Jun; 48(6):1594-601. PubMed ID: 12794827 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
17. Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Ackerman NR; Rooks WH; Shott L; Genant H; Maloney P; West E Arthritis Rheum; 1979 Dec; 22(12):1365-74. PubMed ID: 518718 [TBL] [Abstract][Full Text] [Related]
18. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis. Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897 [TBL] [Abstract][Full Text] [Related]
20. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers. Demerson CA; Humber LG; Abraham NA; Schilling G; Martel RR; Pace-Asciak C J Med Chem; 1983 Dec; 26(12):1778-80. PubMed ID: 6227748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]